Rybelsus®

Semaglutide

Rybelsus® tablets (semaglutide) is a prescription medicine used in adults with type 2 diabetes mellitus to decrease blood sugar levels. Rybelsus® can be prescribed when other diabetes medicines have been tried without success and should be used together with diet and exercise. Rybelsus® tablets work to lower blood sugar (glucose) levels by increasing how much insulin is released and decreasing glucagon secretion. This medicine also may slow gastric emptying after eating.
more
Package Per pill Price Savings Order
90 tablet
Free AirMail shipping Hot
BGN 28.01
BGN 2520.90BGN 28.01
BGN 335.95
60 tablet
Free AirMail shipping Hot
BGN 29.88
BGN 1792.61BGN 29.88
BGN 111.95
30 tablet
Free AirMail shipping Hot
BGN 31.74
BGN 952.28BGN 31.74
Package Per pill Price Savings Order
90 tablet
Free AirMail shipping Hot
BGN 33.61
BGN 3025.09BGN 33.61
BGN 167.88
60 tablet
Free AirMail shipping Hot
BGN 34.55
BGN 2072.72BGN 34.55
BGN 55.93
30 tablet
Free AirMail shipping Hot
BGN 35.48
BGN 1064.32BGN 35.48
Package Per pill Price Savings Order
90 tablet
Free AirMail shipping Hot
BGN 40.15
BGN 3613.33BGN 40.15
BGN 167.88
60 tablet
Free AirMail shipping Hot
BGN 41.08
BGN 2464.87BGN 41.08
BGN 55.93
30 tablet
Free AirMail shipping Hot
BGN 42.01
BGN 1260.40BGN 42.01
Rybelsus

Brand(s)

Manufacturer

  • Novo Nordisc India Pvt. Ltd

Disease(s)

  • Type 2 Diabetes Mellitus / High Blood Sugar

Rybelsus® tablets

What is Rybelsus?

Rybelsus tablets (semaglutide) is a prescription medicine used in adults with type 2 diabetes mellitus to decrease blood sugar levels. Rybelsus can be prescribed when other diabetes medicines have been tried without success, and should be used together with diet and exercise.

Rybelsus tablets work to lower blood sugar (glucose) levels by increasing how much insulin is released and decreasing glucagon secretion. This medicine also may slow gastric emptying after eating. Rybelsus is from the class of medicines called GLP-1 receptor agonists.
Rybelsus is not for treating type 1 diabetes.
Rybelsus was first approved by the FDA on September 20, 2019.

Warnings

You should not use Rybelsus if you have multiple endocrine neoplasia type 2 (tumors in your glands), a personal or family history of medullary thyroid cancer, insulin-dependent diabetes, or diabetic ketoacidosis.
Call your doctor at once if you have signs of a thyroid tumor, such as swelling or a lump in your neck, trouble swallowing, a hoarse voice, or shortness of breath.